| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |